Crisanta (Yasmin)3 0.03mg

$15.75

Each Crisanta contains 21 pills of Drospirenone & Ethinel Estradiol hormone. It is used as a birth control for women and for treating acne in females.

Active Ingrediant: Drospirenone & Ethinel Estradiol
Generic Name: Crisanta
Manufacturer: Cipla Limited
Strength: 3 0.03mg
Dosage Type: Tablet
Packaging Type: Blister in Box
Contains: 21 Tab

Inquire Us

Medication Safety Issues

Sound-alike/look-alike issues:

Yaz may be confused with Beyaz, Yasmin

Storage/Stability

Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F).

Adverse Reactions

Frequency not defined. Reactions listed are based on reports for other agents in this same pharmacologic class (oral contraceptives) and may not be specifically reported for drospirenone/ethinyl estradiol.

Increased risk or evidence of association with use:

Cardiovascular: Arterial thromboembolism, cerebral thrombosis, hypertension, local thrombophlebitis, mesenteric thrombosis, myocardial infarction, pulmonary embolism, retinal thrombosis
Central nervous system: Cerebral hemorrhage
Gastrointestinal: Gallbladder disease
Hepatic: Hepatic adenoma, hepatic neoplasm (benign)
Adverse reactions considered drug related:
Cardiovascular: Edema, worsening of varicose veins
Central nervous system: Depression, exacerbation of tics, migraine
Dermatologic: Allergic skin rash, chloasma
Endocrine & metabolic: Amenorrhea, breast changes (breast hypertrophy, breast secretion, breast tenderness, mastalgia), decreased serum folate level, exacerbation of porphyria, menstrual disease (menstrual flow changes), weight changes
Gastrointestinal: Abdominal cramps, bloating, carbohydrate intolerance, nausea, vomiting
Genitourinary: Breakthrough bleeding, cervical ectropion, cervical erosion, change in cervical secretions, decreased lactation (with use immediately postpartum), infertility (temporary), spotting, vulvovaginal candidiasis
Hepatic: Cholestatic jaundice
Hypersensitivity: Anaphylaxis/anaphylactoid reaction (including angioedema, circulatory shock, respiratory collapse, urticaria)
Neuromuscular & skeletal: Exacerbation of systemic lupus erythematosus
Ophthalmic: Change in corneal curvature (steepening), contact lens intolerance
Adverse reactions in which association is not confirmed or denied:
Cardiovascular: Budd-Chiari syndrome
Central nervous system: Dizziness, headache, nervousness
Dermatologic: Acne vulgaris, erythema multiforme, erythema nodosum, loss of scalp hair
Endocrine & metabolic: Change in libido, hirsutism, porphyria, premenstrual syndrome
Gastrointestinal: Change in appetite, colitis, pancreatitis
Genitourinary: Cystitis-like syndrome, dysmenorrhea, vaginitis
Hematologic & oncologic: Hemolytic-uremic syndrome, hemorrhagic eruption
Ophthalmic: Cataract, optic neuritis (with or without partial or complete loss of vision)
Renal: Renal insufficiency